Principal Investigator
Maria Carpintero
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20210080
Clinical Trial Summary
A Multicenter, Randomized, Double-blind, Placebo controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants with Moderately to Severely Active Systemic Lupus Erythematosus
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Bethly Aubourg
Phone Number
+1 (305) 2438567
Email
b.aubourg@miami.edu